Bragar Eagel & Squire, P.C. is Investigating Johnson & Johnson (JNJ) on Behalf of Stockholders and Encourages JNJ Investors to Contact the Firm
December 14, 2018 18:45 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Johnson & Johnson (NYSE: JNJ). Our investigation concerns whether Johnson...
Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations
January 09, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
May 09, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
Established CPG Brands Named Most Engaging According to Landor Pulse
April 25, 2017 10:00 ET
|
Landor
NEW YORK, April 25, 2017 (GLOBE NEWSWIRE) -- When it comes to consumer packaged goods (CPG), established personal care and food brands—rather than newcomers born in the age of social media—dominate...
SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
March 21, 2017 09:33 ET
|
SPR Therapeutics, LLC
CLEVELAND, March 21, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, LLC, a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and acute pain,...
Antimicrobial Coatings Market To Focus On R&D For Future Innovations As Super-Resistant Microbes Develop - IndustryARC
March 09, 2017 09:00 ET
|
IndustryARC
Hyderabad, March 09, 2017 (GLOBE NEWSWIRE) -- The report “Antimicrobial Coatings Market: By Product Type (Antimicrobial Powder Coatings, Surface Modifications and Coatings) By End-User (HVAC,...
Agile Therapeutics Announces Positive Top-line Phase 3 Results
January 03, 2017 16:11 ET
|
Agile Therapeutics, Inc.
Resubmission of Twirla® New Drug Application Expected to Address FDA’s Complete Response LetterCompany Plans to Resubmit NDA in First Half of...
Boyden's Leadership Series Features Dean Foods’ Ralph Scozzafava
August 31, 2016 05:45 ET
|
Boyden
DALLAS, Aug. 31, 2016 (GLOBE NEWSWIRE) -- Boyden, a global leader in executive search, today released a new issue of its Leadership Series, featuring an in-depth interview with Ralph Scozzafava,...
Diabetes “Selfcare” Demands Retail, Health Care Collaboration & Innovation
August 18, 2016 16:53 ET
|
GMDC
COLORADO SPRINGS, Colo., Aug. 18, 2016 (GLOBE NEWSWIRE) -- According to research from the Global Market Development Center, the shift in diabetic patient care from hospitals to at-home has created...
Agile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors
July 28, 2016 16:11 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 28, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced the appointment of Seth H. Z. Fischer to the Company's Board of Directors, effective July...